forecast
Biotech in Bear Market Creates Entry Opportunity
Biotech has been in a bear market for three years, so assets are cheap while innovation is booming, making the current period a good tactical time for investors to enter the sector as the headwind may be turning into a tailwind.
forecastpending
Speaker
RodEvidence Quote
“from a short-term tactical basis as well for people looking to get into the space, it's probably a very good time to consider that.”
Created: 11/13/2026, 1:54:32 PM
Your notes
Loading notes...